CVS Health Corp. (NYSE: CVS) reported on Tuesday higher revenue in the third quarter, as the retail pharmacy chain grew its network and got a boost from an increase in same-store prescription volumes. The Company also said it anticipates its acquisi..

Spark Therapeutics Inc (NASDAQ: ONCE) Luxturna, the first gene therapy in the U.S., has been approved by the Food and Drug Administration. The gene therapy is intended to treat a rare, inherited retinal disease that could possibly cause blindness. U..

While investors were pitched the multiple benefits of the $69 billion CVS Health Corp (NYSE: CVS) - Aetna Inc (NYSE: AET) merger, the former pitched to its shareholders and the general public that this merger could transform the drugstores owned by ..